Nedisertib Uses, Dosage, Side Effects and more
Nedisertib is under investigation in clinical trial NCT03770689 (Study of M3814 in Combination With Capecitabine and Radiotherapy in Rectal Cancer).
| Trade Name | Nedisertib |
| Generic | Nedisertib |
| Type | |
| Formula | C24H21ClFN5O3 |
| Weight | Average: 481.91 Monoisotopic: 481.1316954 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
